Neurocrine Biosciences Inc.

05/08/2024 | Press release | Distributed by Public on 05/08/2024 06:38

Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1117567 in Healthy Adults